Dr. Mita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd
San Antonio, TX 78229Phone+1 210-450-1000Fax+1 210-450-1150
Summary
- Monica Mita, M.Sc., M.H.D.S., is a medical oncologist at Hoag Family Cancer Institute specializing in breast cancer and development of new therapies for cancer. An accomplished researcher, Dr. Mita has focused on phase I clinical trials in oncology, novel drugs and targeted therapies. She has served as the principal investigator and co-principal investigator on over 100 research studies. After earning her Medical Degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, she completed her specialty training in cancer research at Paul Brousse Hospital in Villejuif, France and the Rene Huguenin Center in Saint-Cloud, France, including obtaining a Masters Degree in Science. She received additional specialty training in oncology at the Claudius Regaud Center, Purpan Hospital, the Saint-Antoine Hospital and Childrens Hospital, in France. Dr. Mita completed an Advanced Oncology Drug Development fellowship and an Oncology fellowship at the University of Texas, Health Science Center in San Antonio, Texas. She also completed an executive master’s degree in Health Delivery Science from Cedars-Sinai Medical Center. Dr. Mita has authored and co-authored more than 200 clinical abstracts, primarily focusing on the effects of various drugs on breast cancer treatment. She has given numerous lectures and presented more than 100 abstracts internationally. Dr. Mita is a member of the American Society for Clinical Oncology, the American Association for Cancer Research and the Southwest Oncology Group, Breast and Early Therapeutics.
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
- Carol Davila University of Medicine and PharmacyClass of 1992
Certifications & Licensure
- CA State Medical License 2011 - 2025
- TX State Medical License 2006 - 2025
- AL State Medical License 2005 - 2024
Clinical Trials
- Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma Start of enrollment: 2008 Aug 01
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors Start of enrollment: 2007 Nov 01
- S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsSingle-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.Stephen L Shiao, Kenneth H Gouin 3rd, Nathan Ing, Alice Ho, Reva Basho
Cancer Cell. 2024-01-08 - 13 citationsAKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.Maysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, Elisa Baldelli, Emna El Gazzah
NPJ Precision Oncology. 2023-02-16 - 21 citationsOncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas.Jennifer S. Carew, Claudia M. Espitia, Weiguo Zhao, Monica M. Mita, Alain C. Mita
Oncotarget. 2017-09-30
Lectures
- Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory mali...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- New Therapeutics in Oncology: The Road to Personalized MedicineCedars Sinai Medical Center, Los Angeles, California - 10/26/2012
Press Mentions
- Hoag Taps 2 Oncology Leaders from Cedars-SinaiApril 26th, 2024
- One Man’s Search for the DNA Data That Could Save His LifeNovember 19th, 2020
- Forever Young? There’s Officially an Anti-Aging Pill for DogsOctober 8th, 2016
- Join now to see all
Professional Memberships
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: